[HTML] mdpi.com

[HTML][HTML] The role of cell-free DNA in cancer treatment decision making

A Telekes, A Horváth - Cancers, 2022 - mdpi.com
Simple Summary The aim of this review is to evaluate the present status of the use of cell-
free DNA and its fraction of circulating tumor DNA (ctDNA) because this year July 2022, an …
被引用次数：13 相关文章

The Role of Cell-Free DNA in Cancer Treatment Decision Making.

A Telekes, A Horváth - Cancers, 2022 - search.ebscohost.com
Abstract Simple Summary: The aim of this review is to evaluate the present status of the use
of cell-free DNA and its fraction of circulating tumor DNA (ctDNA) because this year July …

The Role of Cell-Free DNA in Cancer Treatment Decision Making.

A Telekes, A Horváth - Cancers, 2022 - europepmc.org
The aim of this review is to evaluate the present status of the use of cell-free DNA and its
fraction of circulating tumor DNA (ctDNA) because this year July 2022, an ESMO guideline …

The Role of Cell-Free DNA in Cancer Treatment Decision Making

A Telekes, A Horváth - Cancers, 2022 - pubmed.ncbi.nlm.nih.gov
The aim of this review is to evaluate the present status of the use of cell-free DNA and its
fraction of circulating tumor DNA (ctDNA) because this year July 2022, an ESMO guideline …
[HTML] nih.gov

[HTML][HTML] The Role of Cell-Free DNA in Cancer Treatment Decision Making

A Telekes, A Horváth - Cancers, 2022 - ncbi.nlm.nih.gov
The aim of this review is to evaluate the present status of the use of cell-free DNA and its
fraction of circulating tumor DNA (ctDNA) because this year July 2022, an ESMO guideline …

The Role of Cell-Free DNA in Cancer Treatment Decision Making

A Telekes, A Horváth - Cancers, 2022 - search.proquest.com
The aim of this review is to evaluate the present status of the use of cell-free DNA and its
fraction of circulating tumor DNA (ctDNA) because this year July 2022, an ESMO guideline …